The most common cancer for women throughout the world is breast cancer. The best way to raise the survival rates in these patients is early detection. Although there are different treatments available for neutralization of tumors, more than 500,000 women died from breast cancer only in 2011.
The European Breast Cancer Conference in Amsterdam included the presentation of one research by the Cancer Research UK-funded trial, which shows that a pair of drugs can eliminate certain types of breast cancer in only eleven days. According to the new finding, some women with breast cancer might never need chemo.
The two drugs Lapatinib and Herceptin are commonly used in the treatment of one type of breast cancer, following tumor-removal surgery and chemo. The trial analyzed their effects, and discovered that they both target HER2- protein that drives growth of some types of breast cancer, even the aggressive variants.
The research included 257 women with HER2- positive breast cancer who received the two drugs right before they needed surgery. In a period of two weeks, 11% of the cancers have completely disappeared, while 17% have shrunken.
Researchers were shocked that this drug combination could in some cases completely cure breast cancer patients. This study is small but important for breast cancer sufferers, as HER2-fueled breast cancers have more chances to return than others.